Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke

Neurology

Volumn 60, Issue 9, 2003, Pages 1447-1451

  Kernan, Walter N ^a   Inzucchi, S E ^a   Viscoli, C M ^a   Brass, L M ^a   Bravata, D M ^a   Shulman, G I ^a   McVeety, J C ^a   Horwitz, R I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISABILITY; FEMALE; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; RISK; TRANSIENT ISCHEMIC ATTACK;

EID: 0038559587     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000063318.66140.A3     Document Type: Article

References (54)

1. Despres J-P, LaMarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957.
2. Laakso ML, Sarlund H, Salonen R, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991;11:1068-1076.
3. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995;26:956-960.
4. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. Circulation 1996;93:1809-1817.
5. Suzuki M, Shinozaki K, Kanazawa A, et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 1996;28:593-598.
6. Bonora E, Tessari R, Micciolo R, et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Diabetes Care 1997;20:627-631.
7. Shinozaki K, Naritomi H, Shimizu T, et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996;27:37-43.
8. Gertler MM, Leetma HE, Koutrouby RJ, Johnson ED. The assessment of insulin, glucose and lipids in ischemic thrombotic cerebrovascular disease. Stroke 1975;6:77-84.
9. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men. The 22 year follow-up results of the Helsinki Policemen Study. Stroke 1998;29:1860-1866.
10. Folsom AR, Rasmussen ML, Chambless LE, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care 1999;22:1077-1083.
11. Defronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. J Med 1997;50:191-197.
12. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357.
13. van Loon BJP. The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistance. Metabolism 1993;42:945-949.
14. Steinberg HO, Chaker J, Leaming R, Johnson A, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 1996;97:2601-2610.
15. Stout RW. Insulin and atheroma. 20-Yr perspective. Diabetes Care 1990;113:631-654.
16. Lindahl B, Dinesen B, Eliasson M, Roder M, Hallmans G, Stegmayr B. High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke 2000;31:2936-2941.
17. Tonino RF. Effect of physical training on the insulin resistance of aging. Am J Physiol 1989;256:E352-E356.
18. Huff TA, Lebovitz HE, Heyman A, Davis L. Serial changes in glucose utilization and insulin and growth hormone secretion in acute cerebrovascular disease. Stroke 1972;3:543-552.
19. Rankin J. Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scot Med J 1957;2:200-215.
20. McDowell I, Newell C. Measuring health. New York: Oxford University Press, 1996.
21. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-1470.
22. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men. The 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998;98:398-404.
23. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987;64:1169-1173.
24. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. Diabetes 1996;45:742-748.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23:S4-S19.
26. Barnett HJM, Gunton RW, Eliasziw M, et al. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA 2000;283:1429-1480.
27. Expert Panel of the Identification Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-1867.
28. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 1987;317:521-526.
29. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996;144:1143-1150.
30. Association AD. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1999;22(suppl 1):S22-41.
31. McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-464.
32. Rowe JW, Minaker KL, Pallotta JA. Characterization of the insulin resistance of aging. J Clin Invest 1983;71:1581-1587.
33. Kriska AM, Pereira MA, Hanson RL, et al. Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care 2001;24:1175-1180.
34. Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM. Demonstration of a relationship between level of physical training an insulin-stimulated glucose utilization in normal humans. Diabetes 1983;32:408-411.
35. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-174.
36. Falkner B, Kushner H, Tulenko T, Sumner AE, Marsh JB. Insulin sensitivity, lipids, and blood pressure in young American blacks. Atheroscler Thromb Vasc Biol 1995;15:1798-1804.
37. Ferrannini E. Physiological and metabolic consequences of obesity. Metabolism 1995;44:15-17.
38. Krentz AJ. Insulin resistance. BMJ 1996;313:1385-1389.
39. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest 1980;65:1272-1284.
40. Despres J-P, Nadeau A, Tremblay A, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989;38:304-309.
41. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141-146.
42. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994;93:2365-2371.
43. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996;93:1331-1333.
44. Caro JF. Clinical Review 26. Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991;73:691-695.
45. Howard G, Bergman R, Wagenknecht LE, et al. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model." Ann Epidemiol 1998;8:358-369.
46. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
47. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
48. Bonora E, Targher G, Alberiche M, et al. Homeostatic model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
49. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000;23:171-175.
50. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
51. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI. Insulin resistance and risk for stroke. Neurology 2002;59:809-815.
52. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:121-141.
53. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154-160.
54. Jorgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Stoier M, Olsen TS. Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil 1995;76:406-412.